NMDA-dependent postsynaptic long-term potentiation in CA1  hippocampal neurons
    long-term synaptic potentiation (LTP) is a cellular model of the  activity-dependent enhancement of synaptic transmission in brain. Specific synapses  employ different types of LTP mechanisms. NMDA receptor-dependent LTP in the CA1 region of the hippocampus remain the  most extensively studied form of synaptic plasticity, and therefore is considered  prototypic. [1], [2], [3].
    LTP can be divided into two major stages. The early-LTP process involves such  processes as activation of receptors by L-Glutamic acid, Ca("2+) current, by signaling  mechanisms that provide additional activation of receptors, retrograde transport of  agents to vesicles, and others. Expression of late-LTP genes is induced and new proteins  are synthesized. Each stage can be additionally divided according to duration, time of  initiation, and signaling [1], [3].
    L-Glutamic acid released from presynaptic neurons activates receptor-channels on the  surface of postsynaptic membrane. Activation of AMPA receptor leads to depolarization of the  membrane. This allows overcoming the Mg(2+) block of NMDA receptor. Influx of  Ca("2+) via  these channels leads to activation of Calmodulin and CaMK II. The latter phosphorylates and  activates AMPA receptor. Ca("2+) plays a critical role in the  induction of LTP processes, possibly via participation in the induction of the retrograde  agent transport [3], [4]. The nature of these agents however is  yet unknown and is being actively debated. Possible candidates are Arachidonic acid,  NO,  NO, and  BDNF [1], [2], [5], [6]. mGluR1 is also activated by  L-Glutamic acid. It transforms G-protein alpha-q and induces Phospholipase C beta  (PLC-beta) activation with subsequent release of IP3 and 1,2-Diacyglycerol . IP3 binding to  IP3 receptor leads to Ca("2+) transport from  endoplasmic reticulum to cytoplasm. 1,2-Diacyglycerol  and Ca("2+)  participate in activation of the Protein kinase C (PKC) [3]. PKC, probably,  PKC-alpha in  particular [7], phosphorylates NMDA receptor subunits. This reduces Mg(2+) block  of NMDA receptor and leads to its activation  [3], [8]. Calmodulin  activates adenylate cyclases, which produce Cyclic AMP, leading to activation of  PKA-cat (cAMP-dependent). The latter  phosphorylates and activates AMPA receptor  [4].
    PKA-cat (cAMP-dependent), a common  activator of CREB1, possibly takes part in early and  late-LTP signaling processes [9], [10], [11].  NMDA-induced PKA-cat (cAMP-dependent) participates in translocation  of ERK1/2 into  the nucleus [12]. ERK1/2 then  activates MNK1/  eIF4E, and thereby induces protein synthesis  [11], [13]. Cyclic AMP affects LTP stability by  activating cAMP-GEFI that subsequently activates  ERK1/2[14]. This pathway is  possibly accomplished via activation of RAP-1A and B-Raf [15]. But traditionally,  activation of RAP-1A is linked to a process of long-term  depression, because it activates p38 MAPK and participates in removal of  AMPA receptor from the cell membrane [16], [17].
    NMDA receptor induces a number of pathways  of ERK1/2 activation. NMDA receptor activates Ras protein-specific guanine  nucleotide-releasing factor (RASGRF) signaling to ERK1/2 activation. NR2A binds RASGRF2 [18] and NR2B binds RASGRF1 [19]. Data on biological effects of  NR2A and  NR2B signaling  pathways are controversial. The effects possibly depend on switching of signaling from  activation of ERK1/2 to p38 MAPK and thus  leading to LTP or LTD. Some reports indicate that NR2A and NR2B both induce LTP [17], [19], [20]. Others show that NR2A induces LTP and NR2B induces LTD [18], [21] in CA1 region of the hippocampus, depending on the stage of development of the  organism. RASGRF influences ERK1/2/  CREB1 activation via H-Ras/ c-Raf-1/ MEK1/2 pathway [22].
    NMDA can activate ERK1/2 via  CaMK II [16] and  Shc/ GRB2/ SOS (the latter process was studied in other brain parts [22], at least in neonatal brain).
    ERK1/2 participates in the insertion of  AMPA receptor into the membrane and thus in the  maintenance of the LTP [16], [17], [21].
    ERK1/2 and CaMK II and CaMK IV directly phosphorylate CREB1  [23], [24].
    CREB1 is the most important transcription  regulator of genes involed in LTP. It is activated directly by CaMK II and CaMK IV [23], [24] and ERK1/2 via  p90Rsk [12]. It can activate transcription of other transcription factors, e.g.,  c-Fos [24], or proteins important  for development of LTP, e.g., BDNF. It can also play a role of a  retrograde agent, and to participate in modulation of the actin network in neuronal  spines [25].
    Ca("2+) concentration  elevated during LTP induces activation of eNOS [26], [27].  Production of NO leads to activation of the  soluble Guanylate Cyclase 1, soluble and to Cyclic GMP synthesis. Cyclic GMP participates in activation of Protein kinase G, e.g., Protein kinase G 2, that in turn  activates Ryanodine receptors and elevates Ca("2+) level [28], [29], [30].  Ryanodine receptor 2 is one of possible representatives of such receptors that participate  of long-term memory processes [31].  Ryanodine receptor 3 is possibly important for LTP formation in CA1 However, mechanisms of  its activation by Protein kinase G is still not clear [32]. Protein kinase G also takes part in  ERK1/2 activation of signaling [27]
    NMDA in CA1 also influences Phosphoinositide-3-kinase (PI3K) signaling, leading to  late LTP. Activation of PI3K is induced by Ras (probably, H-Ras). PI3K reg class IA (p85-alpha)/ PI3K cat class IA (p110-alpha) complex  subsequently associates with GluR1 and GluR2, the subunits of AMPA receptor, and promotes their insertion into the membrane [33]. PI3K signaling that leads to activation of AKT(PKB) also promotes GluR1 insertion to membrane [34] and participates in  activation of mTOR  via p70 S6 kinase1, leading to dendrite-wide translation; synaptic-specific  activation is likely to be necessary for long-term synaptic potentiation [35].
          
  Objects list:
         |           1,2-Diacyglycerol         |        1,2-Diacyglycerol  Compound group    |   
       |           AKT(PKB)        |        AKT(PKB) Protein group     |   
       |           AMPA receptor        |        AMPA receptor Complex     |   
       |           B-Raf        |        Serine/threonine-protein kinase B-raf     |   
       |           BDNF        |        Brain-derived neurotrophic factor     |   
       |           CREB1        |        Cyclic AMP-responsive element-binding protein 1     |   
       |           Ca("2+)        |        Chemical IUPAC name calcium(+2) cation    |   
       |           Ca("2+)        |        Chemical IUPAC name calcium(+2) cation    |   
       |           Ca("2+)        |        Chemical IUPAC name calcium(+2) cation    |   
       |           CaMK II        |        CaMK II Complex     |   
       |           CaMK IV        |        Calcium/calmodulin-dependent protein kinase type IV     |   
       |           Calmodulin        |        Calmodulin     |   
       |           Cyclic AMP        |        Chemical IUPAC name (1S,6R,8R,9R)-8-(6-amino-8-bromopurin-9-yl)-3-hydroxy-3-oxo-2,4,7-trioxa-35-phosphabicyclo[4.3.0]nonan-9-ol    |   
       |           Cyclic GMP        |        Chemical IUPAC name Guanosine 3",5"-cyclic phosphate    |   
       |           ERK1/2        |        Erk 1/2 Protein group     |   
       |           GRB2        |        Growth factor receptor-bound protein 2     |   
       |           GluR1        |        Glutamate receptor 1     |   
       |           GluR2        |        Glutamate receptor 2     |   
       |           Guanylate Cyclase 1, soluble        |        soluble Guanylate Cyclase Group of complexes     |   
       |           H-Ras        |        GTPase HRas     |   
       |           IP3        |        Chemical IUPAC name [(1R,2S,3R,4R,5S,6R)-2,4,5-trihydroxy-3,6-diphosphonooxycyclohexyl] dihydrogen phosphate    |   
       |           IP3 receptor        |        A family of receptors for the second messenger inositol 1,4,5-trisphosphate (IP3) Protein group     |   
       |           L-Glutamic acid        |        Chemical IUPAC name (2S)-2-Aminopentanedioic acid    |   
       |           MEK1/2        |        MEK1/2 Protein group     |   
       |           MNK1        |        MAP kinase-interacting serine/threonine-protein kinase 1     |   
       |           NMDA receptor        |        NMDA receptor Group of complexes     |   
       |           NO        |        Chemical IUPAC name Nitric oxide    |   
       |           NR2A        |        Glutamate [NMDA] receptor subunit epsilon-1     |   
       |           NR2B        |        Glutamate [NMDA] receptor subunit epsilon-2     |   
       |           PI3K cat class IA (p110-alpha)        |        Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform     |   
       |           PI3K reg class IA (p85-alpha)        |        Phosphatidylinositol 3-kinase regulatory subunit alpha     |   
       |           PKA-cat (cAMP-dependent)        |        Protein kinase, cAMP-dependent, catalytic Protein group     |   
       |           PKC-alpha        |        Protein kinase C alpha type     |   
       |           Protein kinase G        |        Protein kinase G Protein group     |   
       |           Protein kinase G 2        |        cGMP-dependent protein kinase 2     |   
       |           RAP-1A        |        Ras-related protein Rap-1A     |   
       |           RASGRF1        |        Ras-specific guanine nucleotide-releasing factor 1     |   
       |           RASGRF2        |        Ras-specific guanine nucleotide-releasing factor 2     |   
       |           Ryanodine receptor 2        |        Ryanodine receptor 2     |   
       |           Ryanodine receptor 3        |        Ryanodine receptor 3     |   
       |           SOS        |        SOS Protein group     |   
       |           Shc        |        SHC-transforming protein 1     |   
       |           c-Fos        |        Proto-oncogene c-Fos     |   
       |           c-Raf-1        |        RAF proto-oncogene serine/threonine-protein kinase     |   
       |           cAMP-GEFI        |        Rap guanine nucleotide exchange factor 3     |   
       |           eIF4E        |        Eukaryotic translation initiation factor 4E     |   
       |           eNOS        |        Nitric oxide synthase, endothelial     |   
       |           mGluR1        |        Metabotropic glutamate receptor 1     |   
       |           mTOR        |        Serine/threonine-protein kinase mTOR     |   
       |           p70 S6 kinase1        |        Ribosomal protein S6 kinase beta-1     |   
       |           p90Rsk        |        p90 ribosomal S6 kinases Protein group     |   
    
								
									
										References:
									
									
-  Malenka RC, Bear MF 
	
			LTP and LTD: an embarrassment of riches.
				Neuron 2004 Sep 30;44(1):5-21 
 
-  Miyamoto E 
	
			Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus.
				Journal of pharmacological sciences 2006;100(5):433-42 
 
-  Reymann KG, Frey JU 
	
			The late maintenance of hippocampal LTP: requirements, phases, 'synaptic tagging', 'late-associativity' and implications.
				Neuropharmacology 2007 Jan;52(1):24-40 
 
-  Xia Z, Storm DR 
	
			The role of calmodulin as a signal integrator for synaptic plasticity.
				Nature reviews. Neuroscience 2005 Apr;6(4):267-76 
 
-  Medina JH, Izquierdo I 
	
			Retrograde messengers, long-term potentiation and memory.
				Brain research. Brain research reviews 1995 Sep;21(2):185-94 
 
-  Tao HW, Poo M 
	
			Retrograde signaling at central synapses.
				Proceedings of the National Academy of Sciences of the United States of America 2001 Sep 25;98(20):11009-15 
 
-  Moriguchi S, Han F, Nakagawasai O, Tadano T, Fukunaga K 
	
			Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice.
				Journal of neurochemistry 2006 Apr;97(1):22-9 
 
-  Chen L, Huang LY 
	
			Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation.
				Nature 1992 Apr 9;356(6369):521-3 
 
-  Abel T, Nguyen PV, Barad M, Deuel TA, Kandel ER, Bourtchouladze R 
	
			Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory.
				Cell 1997 Mar 7;88(5):615-26 
 
-  Duffy SN, Nguyen PV 
	
			Postsynaptic application of a peptide inhibitor of cAMP-dependent protein kinase blocks expression of long-lasting synaptic potentiation in hippocampal neurons.
				The Journal of neuroscience : the official journal of the Society for Neuroscience 2003 Feb 15;23(4):1142-50 
 
-  Banko JL, Hou L, Klann E 
	
			NMDA receptor activation results in PKA- and ERK-dependent Mnk1 activation and increased eIF4E phosphorylation in hippocampal area CA1.
				Journal of neurochemistry 2004 Oct;91(2):462-70 
 
-  Impey S, Obrietan K, Wong ST, Poser S, Yano S, Wayman G, Deloulme JC, Chan G, Storm DR 
	
			Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation.
				Neuron 1998 Oct;21(4):869-83 
 
-  Klann E, Dever TE 
	
			Biochemical mechanisms for translational regulation in synaptic plasticity.
				Nature reviews. Neuroscience 2004 Dec;5(12):931-42 
 
-  Gelinas JN, Banko JL, Peters MM, Klann E, Weeber EJ, Nguyen PV 
	
			Activation of exchange protein activated by cyclic-AMP enhances long-lasting synaptic potentiation in the hippocampus.
				Learning & memory (Cold Spring Harbor, N.Y.) 2008 Jun;15(6):403-11 
 
-  de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL 
	
			Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP.
				Nature 1998 Dec 3;396(6710):474-7 
 
-  Zhu JJ, Qin Y, Zhao M, Van Aelst L, Malinow R 
	
			Ras and Rap control AMPA receptor trafficking during synaptic plasticity.
				Cell 2002 Aug 23;110(4):443-55 
 
-  Zhu Y, Pak D, Qin Y, McCormack SG, Kim MJ, Baumgart JP, Velamoor V, Auberson YP, Osten P, van Aelst L, Sheng M, Zhu JJ 
	
			Rap2-JNK removes synaptic AMPA receptors during depotentiation.
				Neuron 2005 Jun 16;46(6):905-16 
 
-  Li S, Tian X, Hartley DM, Feig LA 
	
			Distinct roles for Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and Ras-GRF2 in the induction of long-term potentiation and long-term depression.
				The Journal of neuroscience : the official journal of the Society for Neuroscience 2006 Feb 8;26(6):1721-9 
 
-  Krapivinsky G, Krapivinsky L, Manasian Y, Ivanov A, Tyzio R, Pellegrino C, Ben-Ari Y, Clapham DE, Medina I 
	
			The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1.
				Neuron 2003 Nov 13;40(4):775-84 
 
-  Bartlett TE, Bannister NJ, Collett VJ, Dargan SL, Massey PV, Bortolotto ZA, Fitzjohn SM, Bashir ZI, Collingridge GL, Lodge D 
	
			Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus.
				Neuropharmacology 2007 Jan;52(1):60-70 
 
-  Kim MJ, Dunah AW, Wang YT, Sheng M 
	
			Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking.
				Neuron 2005 Jun 2;46(5):745-60 
 
-  Tian X, Gotoh T, Tsuji K, Lo EH, Huang S, Feig LA 
	
			Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB.
				The EMBO journal 2004 Apr 7;23(7):1567-75 
 
-  Wu GY, Deisseroth K, Tsien RW 
	
			Activity-dependent CREB phosphorylation: convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway.
				Proceedings of the National Academy of Sciences of the United States of America 2001 Feb 27;98(5):2808-13 
 
-  Kasahara J, Fukunaga K, Miyamoto E 
	
			Activation of calcium/calmodulin-dependent protein kinase IV in long term potentiation in the rat hippocampal CA1 region.
				The Journal of biological chemistry 2001 Jun 29;276(26):24044-50 
 
-  Rex CS, Lin CY, Kramár EA, Chen LY, Gall CM, Lynch G 
	
			Brain-derived neurotrophic factor promotes long-term potentiation-related cytoskeletal changes in adult hippocampus.
				The Journal of neuroscience : the official journal of the Society for Neuroscience 2007 Mar 14;27(11):3017-29 
 
-  Haley JE, Schaible E, Pavlidis P, Murdock A, Madison DV 
	
			Basal and apical synapses of CA1 pyramidal cells employ different LTP induction mechanisms.
				Learning & memory (Cold Spring Harbor, N.Y.) 1996 Nov-Dec;3(4):289-95 
 
-  Chien WL, Liang KC, Teng CM, Kuo SC, Lee FY, Fu WM 
	
			Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole.
				Molecular pharmacology 2003 Jun;63(6):1322-8 
 
-  Lu YF, Hawkins RD 
	
			Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus.
				Journal of neurophysiology 2002 Sep;88(3):1270-8 
 
-  Monfort P, Muñoz MD, Kosenko E, Felipo V 
	
			Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
				The Journal of neuroscience : the official journal of the Society for Neuroscience 2002 Dec 1;22(23):10116-22 
 
-  Wu H, Zhou Y, Xiong ZQ 
	
			Transducer of regulated CREB and late phase long-term synaptic potentiation.
				The FEBS journal 2007 Jul;274(13):3218-23 
 
-  Cavallaro S, Meiri N, Yi CL, Musco S, Ma W, Goldberg J, Alkon DL 
	
			Late memory-related genes in the hippocampus revealed by RNA fingerprinting.
				Proceedings of the National Academy of Sciences of the United States of America 1997 Sep 2;94(18):9669-73 
 
-  Balschun D, Wolfer DP, Bertocchini F, Barone V, Conti A, Zuschratter W, Missiaen L, Lipp HP, Frey JU, Sorrentino V 
	
			Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning.
				The EMBO journal 1999 Oct 1;18(19):5264-73 
 
-  Man HY, Wang Q, Lu WY, Ju W, Ahmadian G, Liu L, D'Souza S, Wong TP, Taghibiglou C, Lu J, Becker LE, Pei L, Liu F, Wymann MP, MacDonald JF, Wang YT 
	
			Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons.
				Neuron 2003 May 22;38(4):611-24 
 
-  Qin Y, Zhu Y, Baumgart JP, Stornetta RL, Seidenman K, Mack V, van Aelst L, Zhu JJ 
	
			State-dependent Ras signaling and AMPA receptor trafficking.
				Genes & development 2005 Sep 1;19(17):2000-15 
 
-  Cammalleri M, Lütjens R, Berton F, King AR, Simpson C, Francesconi W, Sanna PP 
	
			Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1.
				Proceedings of the National Academy of Sciences of the United States of America 2003 Nov 25;100(24):14368-73